Augmedix, Inc. (AUGX) has a consensus analyst rating of Buy, based on 6 analysts covering the stock. Of those, 4 recommend buying, 2 recommend holding, and 0 recommend selling.
The analyst consensus price target for AUGX is $2.67, representing a +13.9% upside from the current price of $2.345. Price targets range from a low of $1.50 to a high of $3.50.
